Saint Luke's Health System
43
2
4
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.6%
8 terminated/withdrawn out of 43 trials
76.5%
-10.0% vs industry average
16%
7 trials in Phase 3/4
31%
8 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (43)
TRAjectories and CLinical ExpeRiences of ICD Therapy Study
Role: collaborator
Outcomes of Surgically Ineligible Patients With Multivessel CAD
Role: lead
The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry
Role: lead
Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)
Role: lead
STAR and Deferred Stenting Study
Role: lead
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
Role: collaborator
Weighted Blankets for IUD Insertion
Role: lead
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
Role: lead
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
Role: lead
Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure
Role: lead
SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia)
Role: lead
SHOWME-PAD (Peripheral Artery Disease)
Role: lead
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
Role: collaborator
Patient Registry Of Magnetic Resonance Imaging in Non-Approved DEvices
Role: lead
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
Role: lead
Initial Management of Patients Receiving a Single Shock (IMPRESS)
Role: lead
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Role: lead
NICOM in Pregnant Women With Heart Disease
Role: lead
Dapagliflozin in Respiratory Failure in Patients With COVID-19
Role: lead
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Role: lead